Epigenetically upregulating TROP2 enhances therapeutic efficacy of TROP2 ADC sacitizumab govitecan

被引：0
|
作者：
Zhao, Ming [1 ]
DiPeri, Timothy P. [1 ]
Raso, Gabriela [1 ]
Rizvi, Yasmeen Q. [1 ]
Zheng, Xiaofeng [1 ]
Evans, Kurt [1 ]
Akcakanat, Argun [1 ]
Yang, Fei [1 ]
Tripathy, Debu [1 ]
Dumbrava, Ecaterina Ileana [1 ]
Damodaran, Senthil [1 ]
Meric-Bernstam, Funda [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1791
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan
    Zhao, Ming
    DiPeri, Timothy P. P.
    Raso, Maria Gabriela
    Zheng, Xiaofeng
    Rizvi, Yasmeen Qamar
    Evans, Kurt W. W.
    Yang, Fei
    Akcakanat, Argun
    Estecio, Marco Roberto
    Tripathy, Debu
    Dumbrava, Ecaterina E. E.
    Damodaran, Senthil
    Meric-Bernstam, Funda
    NPJ BREAST CANCER, 2023, 9 (01)
  • [2] Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan
    Ming Zhao
    Timothy P. DiPeri
    Maria Gabriela Raso
    Xiaofeng Zheng
    Yasmeen Qamar Rizvi
    Kurt W. Evans
    Fei Yang
    Argun Akcakanat
    Marco Roberto Estecio
    Debu Tripathy
    Ecaterina E. Dumbrava
    Senthil Damodaran
    Funda Meric-Bernstam
    npj Breast Cancer, 9
  • [3] Rationale for the development of a differentiated Trop2 ADC
    Mitra, Satyajit K.
    Monteith, William
    Do, Mary
    Tuffy, Greg
    Savage, Scott
    Kang, Jeffrey
    Abuhay, Mastewal
    Losic, Teodora
    Ghone, Sanjeevani
    Haskins, William E.
    Jammalamadaka, Vasu
    Satyal, Sanjeev
    CANCER RESEARCH, 2023, 83 (07)
  • [4] Humanized TROP2 mice provide a preclinical tool for the evaluation of therapeutic drugs targeting TROP2
    Huang, Dexuan
    Shen, Zhiyuan
    Ma, Limei
    Li, Chong
    Jin, Tianquan
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Trop2: From Development to Disease
    McDougall, Annie R. A.
    Tolcos, Mary
    Hooper, Stuart B.
    Cole, Timothy J.
    Wallace, Megan J.
    DEVELOPMENTAL DYNAMICS, 2015, 244 (02) : 99 - 109
  • [6] TROP2 Immunohistochemical Expression in Meningiomas
    Ozkizilkaya, H.
    Ozkizilkaya, H.
    Ogunbona, O. Basit
    DeMonte, F.
    Matsuoka, C. Kamiya
    Lopez-Garcia, C.
    Esquenazi, Y.
    Ballester, L.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 566 - 567
  • [7] Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancer
    Kushiyama, Shuhei
    Yashiro, Masakazu
    Yamamoto, Yurie
    Sera, Tomohiro
    Sugimoto, Atsushi
    Nishimura, Sadaaki
    Togano, Shingo
    Kuroda, Kenji
    Yoshii, Mami
    Tamura, Tatsuro
    Toyokawa, Takahiro
    Tanaka, Hiroaki
    Muguruma, Kazuya
    Nakada, Hiroshi
    Ohira, Masaichi
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (05)
  • [8] Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the Esophagus
    Hoppe, Sascha
    Meder, Lydia
    Gebauer, Florian
    Ullrich, Roland T.
    Zander, Thomas
    Hillmer, Axel M.
    Buettner, Reinhard
    Plum, Patrick
    Puppe, Julian
    Malter, Wolfram
    Quaas, Alexander
    CANCERS, 2022, 14 (19)
  • [9] Trop2 as a target for breast cancer treatment
    Wang, Jianbo
    Day, Ryan
    Dong, Yiyu
    Weintraub, Steven
    Michel, Loren
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [10] The role of Trop2 in prostate cancer: an oncogene, biomarker, and therapeutic target
    Shen, Michelle
    Liu, Shiqin
    Stoyanova, Tanya
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2021, 9 (01): : 73 - 87
12345